Abstract: A compound of formula I wherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.

Abstract: The disclosure relates to compounds of formula (I), which are formyl peptide 2 (FPR2) receptor agonists and/or formyl peptide 1 (FPR1) receptor agonists. The disclosure also provides compositions and methods of using the compounds, for example, for the treatment of atherosclerosis, heart failure, and related diseases.

Abstract: A system, method and apparatus for controller functionality for each of security, monitoring and automation, as well as a bidirectional Internet gateway, is provided. Such functionality is provided by virtue of a configurable architecture that enables a user to adapt the system for the user's specific needs. In addition, functionality for gathering configuration information from a previously-installed security system and using that information in a subsequent takeover of that security system is provided.

Abstract: Cost attribution using resource switching including receiving, by a workbook manager from a first client computing system, a first request for a workbook presenting a dataset from a cloud-based data warehouse, wherein the first request comprises a first user attribute; selecting, by the workbook manager, a first resource warehouse on the cloud-based data warehouse based on the first user attribute, wherein the first resource warehouse tracks resources used to service data requests on the cloud-based data warehouse; retrieving, by the workbook manager, the dataset from the cloud-based data warehouse using the first resource warehouse matched to the first user attribute; and presenting, on the first client computing system by the workbook manager, the workbook presenting the dataset.

Abstract: An intrinsically-safe battery assembly for wireless field devices is provided. The intrinsically-safe battery assembly includes a battery and a circuit board mounted relative to the battery. The circuit board is electrically coupled to the battery and has a plurality of electrical contacts for connection to the wireless field device. The circuit board may include current limiting circuitry electrically interposed between the battery and the plurality of electrical contacts to limit maximum current drawn from the battery below a threshold. A polymeric structure is operably engaged with the battery and is configured to protect the circuit board and plurality of electrical contacts from mechanical impact.

Abstract: An industrial communication module includes a controller and a common interface coupled to the controller. The common interface is configured to couple to a plurality of different types of sensor modules. The industrial communication module includes protocol/output circuitry coupled to the controller and configured to provide an output to a remote device. A sensor module includes a controller and a common interface coupled to the controller. The common interface is configured to couple to a plurality of different types of industrial communication modules. The sensor module includes measurement processing circuitry coupled to the controller and configured to measure an analog electrical characteristic of a sensor and provide a digital indication of the measured analog electrical characteristic to the controller.

Abstract: A modular industrial transmitter includes a communication module and a sensor module. The communication module is configured to communicate with a remote device and has a common interface configured to couple to a plurality of different types of sensor modules. The sensor module is coupled to the common interface of the communication module. Physical coupling of the communication module to the sensor module is performed tool-lessly.

Abstract: A modular industrial transmitter includes a communication module and a sensor module. The communication module is configured to communicate with a remote device and has a common interface configured to couple to a plurality of different types of sensor modules. The sensor module is coupled to the common interface of the communication module. Physical coupling of the communication module to the sensor module is performed tool-lessly.

Abstract: An industrial communication module includes a controller and a common interface coupled to the controller. The common interface is configured to couple to a plurality of different types of sensor modules. The industrial communication module includes protocol/output circuitry coupled to the controller and configured to provide an output to a remote device. A sensor module includes a controller and a common interface coupled to the controller. The common interface is configured to couple to a plurality of different types of industrial communication modules. The sensor module includes measurement processing circuitry coupled to the controller and configured to measure an analog electrical characteristic of a sensor and provide a digital indication of the measured analog electrical characteristic to the controller.

Abstract: A location awareness system including a communication network, and a network operating element coupled to the communication network. At least one anchor network gateway is coupled to the communication network, the at least one anchor network gateway configured to generate a wireless anchor network. A plurality of anchors are configured to couple to one of the at least one anchor network gateway via its respective wireless anchor network. A plurality of tags is each configured to communicate with at least one anchor to provide ranging information for determination of a position of the tag within an area covered by the system.

Abstract: The disclosure relates to compounds of Formula (I), which are formyl peptide 2 (FPR2) receptor agonists and/or formyl peptide 1 (FPR1) receptor agonists. The disclosure also provides compositions and methods of using the compounds, for example, for the treatment of atherosclerosis, heart failure, chronic obstructive pulmonary disease (COPD), and related diseases.

Abstract: A compound of formula I wherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.

Abstract: A single platform for controller functionality for each of security, monitoring and automation, as well as providing a capacity to function as a bidirectional Internet gateway, is provided. Embodiments of the present invention provide such functionality by virtue of a configurable architecture that enables a user to adapt the system for the user's specific needs. Embodiments of the present invention further provide such functionality by providing for installation of removable, modular communication adapters for communication with a variety of devices external to the security, monitoring and automation controller.

Abstract: The disclosure relates to compounds of formula I, which are formyl peptide 2 (FPR2) receptor agonists. The disclosure also provides compositions and methods of using the compounds, for example, for the treatment of atherosclerosis, heart failure, chronic obstructive pulmonary disease (COPD), and related diseases.

Abstract: A compound of formula I wherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.

Abstract: A single platform for controller functionality for each of security, monitoring and automation, as well as providing a capacity to function as a bidirectional Internet gateway, is provided. Embodiments of the present invention provide such functionality by virtue of a configurable architecture that enables a user to adapt the system for the user's specific needs. Embodiments of the present invention further provide such functionality by providing for installation of removable, modular communication adapters for communication with a variety of devices external to the security, monitoring and automation controller.

Abstract: A system, method and apparatus for controller functionality for each of security, monitoring and automation, as well as a bidirectional Internet gateway, is provided. Such functionality is provided by virtue of a configurable architecture that enables a user to adapt the system for the user's specific needs. In addition, functionality for gathering configuration information from a previously-installed security system and using that information in a subsequent takeover of that security system is provided.

Abstract: A single platform for controller functionality for each of security, monitoring and automation, as well as providing a capacity to function as a bidirectional Internet gateway, is provided. Embodiments of the present invention provide such functionality by virtue of a configurable architecture that enables a user to adapt the system for the user's specific needs. Embodiments of the present invention further provide such functionality by providing for installation of removable, modular communication adapters for communication with a variety of devices external to the security, monitoring and automation controller.

Abstract: A system, method and apparatus for controller functionality for each of security, monitoring and automation, as well as a bidirectional Internet gateway, is provided. Such functionality is provided by virtue of a configurable architecture that enables a user to adapt the system for the user's specific needs. In addition, functionality for gathering configuration information from a previously-installed security system and using that information in a subsequent takeover of that security system is provided.

Abstract: The disclosure relates to compounds of formula (I), which are formyl peptide 2 (FPR2) receptor agonists and/or formyl peptide 1 (FPR1) receptor agonists. The disclosure also provides compositions and methods of using the compounds, for example, for the treatment of atherosclerosis, heart failure, and related diseases.